Search

Your search keyword '"Préau, Marie"' showing total 534 results
Start Over Author "Préau, Marie"
534 results on '"Préau, Marie"'

6. Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort

Author

Anota, Amélie, Basset, Mathurine, Charton, Emilie, Bommier, Côme, Efficace, Fabio, Dupuis, Jehan, Cottone, Francesco, Bouabdallah, Krimo K., Mollevi, Caroline, Ysebaert, Loïc, Winter, Audrey, Bijou, Fontanet, Préau, Marie, Chauchet, Adrien, Bernier, Adeline, Fornecker, Luc-Matthieu, Hafirassou, Hadia, Carras, Sylvain, Lachenal, Florence, Lionne-Huyghe, Pauline, Detourmignies, Laurence, Leyronnas, Cécile, Drénou, Bernard, Peyrou, Sandra Le Guyader, Abraham, Julie, Monnereau, Alain, Fouillet, Ludovic, Morschhauser, Franck, Rossi, Cédric, Belot, Aurélien, and Ghesquières, Hervé

Published
2024
Full Text
View/download PDF

15. An Innovative One Health Approach: BIOQUALIM, a Transdisciplinary Research Action Protocol—From Cultivated Biodiversity to Human Health Prevention.

Author

Murat-Ringot, Audrey, Lan, Romain, Fraticelli, Laurie, Fayet, Yohan, Bourgeois, Denis, Nugem, Rita, Piton, Maëva, Goetz, Emmie, Préau, Marie, Dutertre, Fabien, Bernoud-Hubac, Nathalie, Basbous, Lama, Lastmann, Anne, Charreyre, Marie-Thérèse, and Carrouel, Florence

Abstract

Background/Objectives: The "One Health" approach underscores the connection between human, animal, and environmental health, promoting solutions to global challenges like climate change and biodiversity loss. The Planetary Health Diet (PHD) promotes a plant-based diet with organically grown plants to reduce the environmental impact of meat production and decrease the risk of non-communicable diseases (NCDs). The BIOQUALIM project will evaluate the PHD's effectiveness in preventing NCDs like periodontal diseases and cancers through four inter-related studies. Methods: The clinical study will involve volunteers reducing their meat consumption and incorporating einkorn into their diet, allow for analysis of their interdental microbiota, oral health, general health, and quality of life. The chemical analysis will study nutrients and anti-cancer compounds in einkorn and common wheat varieties. The behavioral study will explore PHD knowledge, attitudes, and behaviors related to PHD. The psycho-social study will evaluate the impact of peer-support workshops on plant-based dietary cooking among post-therapy cancer patients. Results: The results are expected to demonstrate that einkorn varieties possess nutritional properties that, when incorporated into the PHD enriched with einkorn, can enhance health markers. This study will identify barriers to and facilitators of PHD adoption and highlight how peer-support workshops can improve dietary adherence. Conclusions: BIOQUALIM's transdisciplinary approach will demonstrate the PHD's role in preventing NCDs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial

Author

Aboulker, Jean-Pierre, Bajos, Nathalie, Baril, Jean-Guy, Besnier, Michel, Binesse, Johan, Carette, Diane, Cattin, Grégoire, Chéret, Antoine, Chidiac, Christian, Choucair, Elias, Delfraissy, Jean-François, Demoulin, Baptiste, Diallo, Alpha, Durant-Zaleski, Isabelle, Doré, Véronique, Etien, Nicolas, Euphrasie, Françoise, Fonsart, Julien, Foubert, Valérie, Gibowski, Séverine, Girard, Gabriel, Guillon, Brigitte, Le Mestre, Soizic, Lert, France, Leturque, Nicolas, Lorente, Nicolas, Mennecier, Anaïs, Morin, Michel, Netzer, Emmanuelle, Otis, Joanne, Pasquet, Armelle, Peytavin, Gilles, Pialoux, Gilles, Préau, Marie, Rabian, Cécile, Rozenbaum, Willy, Sagaon-Teyssier, Luis, Saïdi, Yacine, Saouzanet, Marine, Simon, Marie-Christine, Suzan-Monti, Marie, Thompson, David, Timsit, Julie, Trottier, Benoît, Wainberg, Mark, Antoni, Guillemette, Tremblay, Cécile, Delaugerre, Constance, Charreau, Isabelle, Cua, Eric, Rojas Castro, Daniela, Raffi, François, Chas, Julie, Huleux, Thomas, Spire, Bruno, Capitant, Catherine, Cotte, Laurent, Meyer, Laurence, and Molina, Jean-Michel

Published
2020
Full Text
View/download PDF

22. Questioning the “Ease” in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)

Author

Roucoux, Guillaume, primary, Thonon, Frédérique, additional, Zucman, David, additional, Rey, David, additional, Abgrall, Sophie, additional, Eriksson, Lars E., additional, Préau, Marie, additional, Michels, David, additional, Chéret, Antoine, additional, and Duracinsky, Martin, additional

Published
2024
Full Text
View/download PDF

24. Co-construire un projet de recherche en oncologie avec les personnes concernées : retour d’expérience et leçons apprises

Author

Baillat, Léa, primary, Bauquier, Charlotte, additional, Pannard, Myriam, additional, Piton, Maëva, additional, Denieul, Chantal, additional, Sevenne, Murielle, additional, Gerard, Annick, additional, Mouline, Mouna, additional, Jean-Daubias, Stéphanie, additional, Jacob, Guillemette, additional, and Préau, Marie, additional

Published
2024
Full Text
View/download PDF

25. Would shared decision-making be useful in breast cancer screening programmes? A qualitative study using focus group discussions to gather evidence from French women with different socioeconomic backgrounds

Author

Guigon, Laureline, primary, Sánchez, Laura X. Gil, additional, Petit, Anne-Sophie, additional, Bonniec, Alice Le, additional, Basu, Partha, additional, Rodrigue, Christelle M., additional, Préau, Marie, additional, Soler-Michel, Patricia, additional, and Villain, Patricia, additional

Published
2024
Full Text
View/download PDF

26. Broad range molecular detection methods identify only Borrelia spp. in erythema migrans biopsies and blood of tick-bitten patients

Author

Arowas, Laurence, Botelho-Nevers, Elisabeth, Cazorla, Céline, Chirouze, Catherine, Chrétien, Delphine, Corre-Catelin, Nicole, Eloit, Marc, Frey-Klett, Pascale, Fontanet, Arnaud, Galon, Clémence, Lacombe, Karine, Moutailler, Sara, Pérot, Philippe, Perronne, Véronique, Piquard, Valentine, Préau, Marie, Puppo, Costanza, Tondeur, Laura, Ungeheuer, Marie-Noelle, Vayssier-Taussat, Muriel, and Zayoud, Ayla

Published
2024
Full Text
View/download PDF

28. Organization of psychosocial factors associated with worry about acquiring SARS-CoV-2 among women undergoing cancer treatment: an empirical network comparison approach.

Author

Mabire-Yon, Renaud, Le Bonniec, Alice, Arnaud, Siméone, and Préau, Marie

Subjects
TUMOR treatment, ANXIETY prevention, CROSS-sectional method, WORRY, ATTITUDES toward illness, RESEARCH funding, MENTAL health, QUANTITATIVE research, DESCRIPTIVE statistics, STAY-at-home orders, CANCER patient psychology, SOCIODEMOGRAPHIC factors, WOMEN'S health, DATA analysis software, COVID-19
Abstract

Pandemic-induced anxiety can have adverse mental and somatic health consequences on cancer patients (CP). This study aimed to (1) explore the intricate relationships between worry related to potential SARS-CoV-2 infection, COVID-19 perception, sociodemographic factors, and the perceived effectiveness of lockdown measures and (2) investigate if these relationships differ between cancer patients and individuals without a history of cancer (IWHC). We conducted a cross-sectional quantitative study in France between December 1 and 14, 2020. Network analysis was employed on a sample of 1889 women, including 282 cancer patients and 1607 noncancer individuals. Our findings indicate that CP were 20% more likely to express worry than IWHC. Anxiety is embedded within a complex network involving sociodemographic, cognitive, and emotional factors. The emotional components related to COVID-19 perception were found to play a crucial role. The networks for both groups were observed to be identical. Our study underscores the heightened vulnerability of cancer patients to pandemic-induced anxiety, emphasizing the crucial role of emotional components related to COVID-19 perception. The observed similarities in the anxiety network between cancer patients and those without a history of cancer suggest that universal approaches might be effective across groups. Utilizing the Causal Attitude Network Model, we propose potential methods for managing and reducing individual anxiety levels. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. La recherche communautaire en psychologie sociale

Author

Petit, Anne-Sophie, primary, Pannard, Myriam, additional, Puppo, Costanza, additional, Bauquier, Charlotte, additional, Mabire, Xavier, additional, Préau, Marie, additional, Di Ciaccio, Marion, additional, and Spire, Bruno, additional

Published
2020
Full Text
View/download PDF

34. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

Author

Meyer, L, Capitant, C, Charreau, I, Netzer, E, Leturque, N, Binesse, J, Foubert, V, Saouzanet, M, Euphrasie, F, Carette, D, Guillon, B, Saïdi, Y, Aboulker, J P, Spire, B, Suzan, M, Cattin, G, Demoulin, B, Sagaon-Teyssier, L, Lorente, N, Doré, V, Choucair, E, Le Mestre, S, Mennecier, A, Etien, N, Simon, M C, Diallo, A, Gibowski, S, Delfraissy, J F, Thompson, D, Sas, J, Pankovitch, J, Klein, M, Anis, A, Molina, Jean-Michel, Wainberg, Mark A, Trottier, Benoit, Tremblay, Cécile, Baril, Jean-Guy, Pialoux, Gilles, Cotte, Laurent, Chéret, Antoine, Pasquet, Armelle, Cua, Eric, Besnier, Michel, Rozenbaum, Willy, Chidiac, Christian, Delaugerre, Constance, Bajos, Nathalie, Timsit, Julie, Peytavin, Gilles, Fonsart, Julien, Durand-Zaleski, Isabelle, Meyer, Laurence, Aboulker, Jean-Pierre, Spire, Bruno, Suzan-Monti, Marie, Girard, Gabriel, Castro, Daniela Rojas, Préau, Marie, Morin, Michel, Thompson, David, Capitant, Catherine, Mennecier, Anaïs, Choucair, Elias, Doré, Véronique, Simon, Marie-Christine, Charreau, Isabelle, Otis, Joanne, Lert, France, Diallo, Alpha, Gibowski, Séverine, Rabian, Cecile, Chas, Julie, Tremblay, Cecile, Rojas-Castro, Daniela, Bernaud, Camille, Pintado, Claire, Sagaon-Teyssier, Luis, Mestre, Soizic Le, Ponscarme, Diane, and Doré, Veronique

Published
2017
Full Text
View/download PDF

37. Disclosure of HIV Status Beyond Sexual Partners by People Living with HIV in France: A Call for Help? Results from the National Cross-Sectional Survey ANRS-VESPA2

Author

Marcellin, Fabienne, Suzan-Monti, Marie, Vilotitch, Antoine, Sagaon-Teyssier, Luis, Mora, Marion, Dray-Spira, Rosemary, Préau, Marie, Lert, France, Spire, Bruno, Lert, France, Spire, Bruno, Carrieri, Maria Patrizia, Dray-Spira, Rosemary, Hamelin, Christine, Lorente, Nicolas, Préau, Marie, Suzan-Monti, Marie, Marcellin, Fabienne, Duracinsky, Martin, The ANRS VESPA2 Study Group, and with the collaboration of Marion Mora

Published
2017
Full Text
View/download PDF

40. Existe-t-il un profil spécifique de perception du risque de COVID-19 chez les personnes atteintes d'un cancer? une étude transversale.

Author

Mabire-Yon, Renaud, Siméone, Arnaud, Marmorat, Thibaud, Petit, Anne-Sophie, Perray, Mathilde, Puppo, Costanza, Bauquier, Charlotte, Della Vecchia, Claire, Picard, Hervé, and Préau, Marie

Subjects
CROSS-sectional method, HEALTH literacy, SECONDARY analysis, PSYCHOLOGICAL distress, RESEARCH funding, QUESTIONNAIRES, LOGISTIC regression analysis, KRUSKAL-Wallis Test, SOCIOECONOMIC factors, PROBABILITY theory, RESIDENTIAL patterns, DESCRIPTIVE statistics, MULTIVARIATE analysis, CHI-squared test, SEVERITY of illness index, ATTITUDE (Psychology), ODDS ratio, STATISTICS, MARITAL status, CANCER patient psychology, RISK perception, DATA analysis software, COVID-19
Abstract

Copyright of Psycho-Oncologie is the property of Tech Science Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

41. Facteurs associés à la crainte de l’infection par la COVID-19 chez des personnes vivant avec le VIH

Author

Piton, Maëva, primary, Della Vecchia, Claire, additional, Mabire, Renaud, additional, Alain, Tristan, additional, Salcedo Robledo, Manuela, additional, Charpentier, Nicolas, additional, Puppo, Costanza, additional, Petit, Anne Sophie, additional, Carpentier, Camille, additional, Perray, Mathilde, additional, Mabire, Xavier, additional, Michels, David, additional, and Préau, Marie, additional

Published
2023
Full Text
View/download PDF

45. Supplemental Material - Psychosocial factors involved in the very rare use of HIV testing among French MSM: a cross-sectional study

Author

Mabire-Yon, Renaud, Di Ciaccio, Marion, Picard, Hervé, Palich, Romain, Supervie, Virginie, and Préau, Marie

Subjects
110309 Infectious Diseases, FOS: Health sciences
Abstract

Supplemental Material for Psychosocial factors involved in the very rare use of HIV testing among French MSM: a cross-sectional study by Renaud Mabire-Yon, Marion Di Ciaccio, Hervé Picard, Romain Palich, Virginie Supervie and Marie Préau in International Journal of STD & AIDS

Published
2023
Full Text
View/download PDF

47. Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment

Author

Protiere, Christel, Arnold, Michael, Fiorentino, Marion, Fressard, Lisa, Lelièvre, Jean D., Mimi, Mohamed, Raffi, François, Mora, Marion, Meyer, Laurence, Sagaon?Teyssier, Luis, Zucman, David, Préau, Marie, Lambotte, Olivier, Spire, Bruno, Suzan?Monti, Marie, Bergmann, J.F., Blacher, J., Blanc, A.P., Delobel, P., Girard, P.M., Goujard, C., Katlama, C., De Lacroix, I., Lafeuillade, A., Lelièvre, J.D., Lepeu, G., Michelet, C., Molina, J.M., Morlat, P., Peyramond, D., Piroth, L., Poizot?Martin, I., Raffi, F., Ragnaud, J.M., Senneville, E., Weiss, L., Yazdanpanh, Y., and Zucman, D.

Subjects
Clinical trials -- Management, AIDS (Disease) -- Research, AIDS research, HIV infection -- Care and treatment, Company business management, Health
Abstract

: Introduction: Despite the advent of HIV cure‐related clinical trials (HCRCT) for people living with HIV (PLWH), the risks and uncertainty involved raise ethical issues. Although research has provided insights into the levers and barriers to PLWH and physicians' participation in these trials, no information exists about stakeholders' preferences for HCRCT attributes, about the different ways PLWH and physicians value future HCRCT, or about how personal characteristics affect these preferences. The results from the present study will inform researchers' decisions about the most suitable HCRCT strategies to implement, and help them ensure ethical recruitment and well‐designed informed consent. Methods: Between October 2016 and March 2017, a discrete choice experiment was conducted among 195 virally controlled PLWH and 160 physicians from 24 French HIV centres. Profiles within each group, based on individual characteristics, were obtained using hierarchical clustering. Trade‐offs between five HCRCT attributes (trial duration, consultation frequency, moderate (digestive disorders, flu‐type syndrome, fatigue) and severe (allergy, infections, risk of cancer) side effects (SE), outcomes) and utilities associated with four HCRCT candidates (latency reactivation, immunotherapy, gene therapy and a combination of latency reactivation and immunotherapy), were estimated using a mixed logit model. Results: Apart from severe SE – the most decisive attribute in both groups – PLWH and physicians made different trade‐offs between HCRCT attributes, the latter being more concerned about outcomes, the former about the burden of participation (consultation frequency and moderate SE). These different trades‐offs resulted in differences in preferences regarding the four candidate HCRCT. PLWH significantly preferred immunotherapy, whereas physicians preferred immunotherapy and combined therapy. Despite the heterogeneity of characteristics within the PLWH and physician profiles, results show some homogeneity in trade‐offs and utilities regarding HCRCT. Conclusions: Severe SE, not outcomes, was the most decisive attribute determining future HCRCT participation. Particular attention should be paid to providing clear information, in particular on severe SE, to potential participants. Immunotherapy would appear to be the best HCRCT candidate for both PLWH and physicians. However, if the risk of cancer could be avoided, gene therapy would become the preferred strategy for the latter and the second choice for the former., Introduction HIV cure research, a desired but risky and “uncomfortable” innovation, raises several ethical questions. More specifically, to test the effectiveness of new HIV cure‐related clinical trials (HCRCT), clinicians must [...]

Published
2020
Full Text
View/download PDF

48. Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis

Author

Liegeon, Geoffroy, Antoni, Guillemette, Pialoux, Gilles, Capitant, Catherine, Cotte, Laurent, Charreau, Isabelle, Tremblay, Cécile, Cua, Eric, Senneville, Eric, Raffi, François, Meyer, Laurence, Molina, Jean?Michel, Meyer, L, Capitant, C, Charreau, I, Netzer, E, Leturque, N, Binesse, J, Foubert, V, Saouzanet, M, Euphrasie, F, Carette, D, Guillon, B, Saïdi, Y, Aboulker, J P., Spire, B, Suzan, M, Cattin, G, Demoulin, B, Sagaon?Teyssier, L, Lorente, N, Doré, V, Choucair, E, Le Mestre, S, Mennecier, A, Etien, N, Simon, M C., Diallo, A, Gibowski, S, Delfraissy, J F., Thompson, D, Sas, J, Pankovitch, J, Klein, M, Anis, A, Wainberg, Mark A., Trottier, Benoit, Baril, Jean?Guy, Chéret, Antoine, Pasquet, Armelle, Hall, Nolwenn, Rozenbaum, Willy, Chidiac, Christian, Delaugerre, Constance, Bajos, Nathalie, Timsit, Julie, Peytavin, Gilles, Fonsart, Julien, Durand?Zaleski, Isabelle, Aboulker, Jean?Pierre, Spire, Bruno, Suzan?Monti, Marie, Girard, Gabriel, Castro, Daniela Rojas, Préau, Marie, Morin, Michel, Thompson, David, Mennecier, Anaïs, Choucair, Elias, Doré, Véronique, Simon, Marie?Christine, Otis, Joanne, Lert, France, Diallo, Alpha, Gibowski, Séverine, and Rabian, Cecile

Subjects
MSM (Men who have sex with men) -- Health aspects, Tenofovir -- Patient outcomes, Glomerular filtration rate -- Testing, Emtricitabine -- Patient outcomes, HIV infection -- Prevention, Health
Abstract

: Introduction: Daily pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) is associated with a small but statistically significant decrease in estimated glomerular filtration rate (eGFR). We assessed the renal safety of on‐demand PrEP with TDF/FTC in HIV‐1 uninfected men. Methods: We used data from the randomized double‐blind placebo‐controlled ANRS‐IPERGAY trial and its open‐label extension conducted between February 2012 and June 2016 among HIV‐uninfected MSM starting on‐demand PrEP. Using linear mixed model, we evaluated the mean eGFR decline from baseline over time and determined risks factors associated with eGFR decline during the study. Results: During the blind phase, with a median follow‐up of 9.4 months, the mean decline slope of eGFR from baseline was −0.88 and −1.53 mL/min/1.73 m[sup.2] per year in the placebo (n = 201) and the TDF/FTC group (n = 198) respectively, with a slope difference of 0.65 mL/min/1.73 m[sup.2] per year (p = 0.27). Including both phases, 389 participants started on‐demand TDF/FTC with a median follow‐up of 19.2 months and a mean decline of eGFR from baseline of −1.14 mL/min/1.73 m[sup.2] per year (p < 0.001). The slope of eGFR reduction was not significantly different in participants with baseline eGFR ≤ 90 mL/min/1.73 m[sup.2] (p = 0.44), age >40 years (p = 0.24) or hypertension (p = 0.21). There was a dose‐response relationship between recent tenofovir exposure and lower eGFR when considering the number of pills taken in the two months prior the visit (eGFR difference of −0.88 mL/min/1.73 m[sup.2] between >15 pills/month vs. ≤15 pills/month, p < 0.01) or plasma tenofovir concentrations at the visit (eGFR difference compared to ≤2 ng/mL: >2 to ≤10ng/mL: −0.98 mL/min/1.73 m[sup.2], >10 to ≤40ng/mL: −1.28 mL/min/1.73 m[sup.2], >40 ng/mL: −1.82 mL/min/1.73 m[sup.2], p < 0.001). Three participants discontinued TDF/FTC for eGFR < 60 mL/min/1.73 m[sup.2] during the OLE phase. No case of Fanconi syndrome was reported. Conclusions: The renal safety of on‐demand PrEP with TDF/FTC was good. The overall reduction and intermittent exposure to TDF/FTC may explain this good renal safety., Introduction Pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF) – emtricitabine (FTC) raises a lot of expectations to hamper HIV epidemic due to its high effectiveness to prevent HIV acquisition [...]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results